The Hidden Influence: Impacts of Residual Dimethylformamide in NDSB‐211 on icIEF Separation for Monoclonal Antibodies
ELECTROPHORESIS · 2025
DOI: 10.1002/elps.70024 ↗Kurz gefasst
Fachartikel in der Zeitschrift ELECTROPHORESIS, 2025. Verfasst von Delaney Doran und 5 weiteren Autor:innen. Beteiligte Einrichtung: Therapeutics Development and Supply-Analytical Development, Janssen Research & Development, LLC, Malvern, Pennsylvania, USA. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Dimethylformamide. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Monoclonal antibodies (mAbs) present analytical challenges due to their inherent heterogeneity and susceptibility to post‐translational modifications (PTMs) during production and storage. Monitoring of charge heterogeneity profiles by imaged capillary isoelectric focusing (icIEF) has been aided by the use of non‐detergent sulfobetaines (NDSBs), particularly NDSB‐211, to enhance protein solubility and stability. When used in a quality control laboratory setting, NDSB‐211 has shown performance variability over time due to residual manufacturing impurities that impact the capillary isoelectric focusing separation. Dimethylformamide (DMF) was detected using 1 H nuclear magnetic resonance (NMR) in several lots of NDSB‐211 that simultaneously produced poor resolution of basic variants of a mAb on icIEF. A parallel spiking study using DMF at 1%–10% (v/v) on 1 H NMR and icIEF illustrates the interference in charge heterogeneity separation when a large amount of DMF is present in the NDSB‐211 reagent. As DMF is not found on the NDSB‐211 certificate of analysis from any vendor, more traditional additives for icIEF are suggested to limit the potential interference for analytical methods.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Therapeutics Development and Supply-Analytical Development, Janssen Research & Development, LLC, Malvern, Pennsylvania, USA.
Zitieren
APA
Doran, D., Myers, M., Moravcevic, K., LaBrenz, S., Wang, P., & Ji, X. (2025). The Hidden Influence: Impacts of Residual Dimethylformamide in NDSB‐211 on icIEF Separation for Monoclonal Antibodies. ELECTROPHORESIS. https://doi.org/10.1002/elps.70024
Vancouver
Doran D, Myers M, Moravcevic K, LaBrenz S, Wang P, Ji X. The Hidden Influence: Impacts of Residual Dimethylformamide in NDSB‐211 on icIEF Separation for Monoclonal Antibodies. ELECTROPHORESIS. 2025. doi:10.1002/elps.70024
BibTeX
@article{Doran2025,
author = {Doran, Delaney and Myers, Matthew and Moravcevic, Katarina and LaBrenz, Steven and Wang, Pinger and Ji, Xiaoying},
title = {The Hidden Influence: Impacts of Residual Dimethylformamide in NDSB‐211 on icIEF Separation for Monoclonal Antibodies},
journal = {ELECTROPHORESIS},
year = {2025},
doi = {10.1002/elps.70024}
}
EUVIMED